Skip to main content
Erschienen in: Journal of Cachexia, Sarcopenia and Muscle 2/2014

01.06.2014 | Original Article

Hypothalamic food intake regulation in a cancer-cachectic mouse model

verfasst von: Jvalini T. Dwarkasing, Miriam van Dijk, Francina J. Dijk, Mark V. Boekschoten, Joyce Faber, Josep M. Argilès, Alessandro Laviano, Michael Müller, Renger F. Witkamp, Klaske van Norren

Erschienen in: Journal of Cachexia, Sarcopenia and Muscle | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Appetite is frequently affected in cancer patients leading to anorexia and consequently insufficient food intake. In this study, we report on hypothalamic gene expression profile of a cancer-cachectic mouse model with increased food intake. In this model, mice bearing C26 tumour have an increased food intake subsequently to the loss of body weight. We hypothesise that in this model, appetite-regulating systems in the hypothalamus, which apparently fail in anorexia, are still able to adapt adequately to changes in energy balance. Therefore, studying changes that occur on appetite regulators in the hypothalamus might reveal targets for treatment of cancer-induced eating disorders. By applying transcriptomics, many appetite-regulating systems in the hypothalamus could be taken into account, providing an overview of changes that occur in the hypothalamus during tumour growth.

Methods

C26-colon adenocarcinoma cells were subcutaneously inoculated in 6 weeks old male CDF1 mice. Body weight and food intake were measured three times a week. On day 20, hypothalamus was dissected and used for transcriptomics using Affymetrix chips.

Results

Food intake increased significantly in cachectic tumour-bearing mice (TB), synchronously to the loss of body weight. Hypothalamic gene expression of orexigenic neuropeptides NPY and AgRP was higher, whereas expression of anorexigenic genes CCK and POMC were lower in TB compared to controls.
In addition, serotonin and dopamine signalling pathways were found to be significantly altered in TB mice. Serotonin levels in brain showed to be lower in TB mice compared to control mice, while dopamine levels did not change. Moreover, serotonin levels inversely correlated with food intake.

Conclusions

Transcriptomic analysis of the hypothalamus of cachectic TB mice with an increased food intake showed changes in NPY, AgRP and serotonin signalling. Serotonin levels in the brain showed to correlate with changes in food intake. Further research has to reveal whether targeting these systems will be a good strategy to avoid the development of cancer-induced eating disorders.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Fearon K et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95.PubMedCrossRef Fearon K et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95.PubMedCrossRef
3.
Zurück zum Zitat Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 1996;381:415–21.PubMedCrossRef Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 1996;381:415–21.PubMedCrossRef
4.
Zurück zum Zitat Qian S et al. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol. 2002;22:5027–35.PubMedCentralPubMedCrossRef Qian S et al. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol. 2002;22:5027–35.PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Laviano A et al. NPY and brain monoamines in the pathogenesis of cancer anorexia. Nutrition. 2008;24:802–5.PubMedCrossRef Laviano A et al. NPY and brain monoamines in the pathogenesis of cancer anorexia. Nutrition. 2008;24:802–5.PubMedCrossRef
7.
Zurück zum Zitat van Norren K et al. Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice. Br J Cancer. 2009;100:713–22.PubMedCentralPubMedCrossRef van Norren K et al. Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice. Br J Cancer. 2009;100:713–22.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat van Eijk HM, Rooyakkers DR, Deutz NE. Rapid routine determination of amino acids in plasma by high-performance liquid chromatography with a 2–3 microns Spherisorb ODS II column. J Chromatogr. 1993;620:143–8.PubMedCrossRef van Eijk HM, Rooyakkers DR, Deutz NE. Rapid routine determination of amino acids in plasma by high-performance liquid chromatography with a 2–3 microns Spherisorb ODS II column. J Chromatogr. 1993;620:143–8.PubMedCrossRef
9.
Zurück zum Zitat Lin K et al. MADMAX—management and analysis database for multiple omics experiments. J Integr Bioinform. 2011;8:160.PubMed Lin K et al. MADMAX—management and analysis database for multiple omics experiments. J Integr Bioinform. 2011;8:160.PubMed
10.
12.
Zurück zum Zitat Bolstad BM et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185–93.PubMedCrossRef Bolstad BM et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185–93.PubMedCrossRef
13.
Zurück zum Zitat Sartor MA et al. Intensity-based hierarchical Bayes method improves testing for differentially expressed genes in microarray experiments. BMC Bioinforma. 2006;7:538.CrossRef Sartor MA et al. Intensity-based hierarchical Bayes method improves testing for differentially expressed genes in microarray experiments. BMC Bioinforma. 2006;7:538.CrossRef
15.
16.
Zurück zum Zitat Tomita T, Kimura S. Regulation of mouse Scgb3a1 gene expression by NF-Y and association of CpG methylation with its tissue-specific expression. BMC Mol Biol. 2008;9:5.PubMedCentralPubMedCrossRef Tomita T, Kimura S. Regulation of mouse Scgb3a1 gene expression by NF-Y and association of CpG methylation with its tissue-specific expression. BMC Mol Biol. 2008;9:5.PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Ding M, Toth LA. mRNA expression in mouse hypothalamus and basal forebrain during influenza infection: a novel model for sleep regulation. Physiol Genomics. 2006;24:225–34.PubMedCrossRef Ding M, Toth LA. mRNA expression in mouse hypothalamus and basal forebrain during influenza infection: a novel model for sleep regulation. Physiol Genomics. 2006;24:225–34.PubMedCrossRef
18.
Zurück zum Zitat Tanaka Y et al. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res. 1990;50:2290–5.PubMed Tanaka Y et al. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res. 1990;50:2290–5.PubMed
19.
Zurück zum Zitat Iizuka N et al. Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma. Int J Cancer. 2002;99:286–91.PubMedCrossRef Iizuka N et al. Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma. Int J Cancer. 2002;99:286–91.PubMedCrossRef
20.
Zurück zum Zitat Soda K et al. Manifestations of cancer cachexia induced by colon 26 adenocarcinoma are not fully ascribable to interleukin-6. Int J Cancer J Int du Cancer. 1995;62:332–6.CrossRef Soda K et al. Manifestations of cancer cachexia induced by colon 26 adenocarcinoma are not fully ascribable to interleukin-6. Int J Cancer J Int du Cancer. 1995;62:332–6.CrossRef
21.
22.
Zurück zum Zitat Murphy KT, et al. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia. Dis Model Mech. 2012;5:533–45. Murphy KT, et al. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia. Dis Model Mech. 2012;5:533–45.
23.
Zurück zum Zitat Aulino P et al. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. BMC Cancer. 2010;10:363.PubMedCentralPubMedCrossRef Aulino P et al. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. BMC Cancer. 2010;10:363.PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Sacchi A, Mauro F, Zupi G. Changes of phenotypic characteristics of variants derived from Lewis lung carcinoma during long-term in vitro growth. Clin Exp Metastasis. 1984;2:171–8.PubMedCrossRef Sacchi A, Mauro F, Zupi G. Changes of phenotypic characteristics of variants derived from Lewis lung carcinoma during long-term in vitro growth. Clin Exp Metastasis. 1984;2:171–8.PubMedCrossRef
25.
Zurück zum Zitat Faber J et al. Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia. Br J Cancer. 2008;99:2029–36.PubMedCentralPubMedCrossRef Faber J et al. Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia. Br J Cancer. 2008;99:2029–36.PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Sonti G, Ilyin SE, Plata-Salaman CR. Anorexia induced by cytokine interactions at pathophysiological concentrations. Am J Physiol. 1996;270:R1394–402.PubMed Sonti G, Ilyin SE, Plata-Salaman CR. Anorexia induced by cytokine interactions at pathophysiological concentrations. Am J Physiol. 1996;270:R1394–402.PubMed
27.
Zurück zum Zitat Rothman RB et al. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Synapse. 2003;50:233–9.PubMedCrossRef Rothman RB et al. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Synapse. 2003;50:233–9.PubMedCrossRef
28.
Zurück zum Zitat Zhang X et al. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science. 2004;305:217.PubMedCrossRef Zhang X et al. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science. 2004;305:217.PubMedCrossRef
29.
Zurück zum Zitat Meguid MM et al. Tumor anorexia: effects on neuropeptide Y and monoamines in paraventricular nucleus. Peptides. 2004;25:261–6.PubMedCrossRef Meguid MM et al. Tumor anorexia: effects on neuropeptide Y and monoamines in paraventricular nucleus. Peptides. 2004;25:261–6.PubMedCrossRef
30.
Zurück zum Zitat Salamone JD, Correa M. Dopamine and food addiction: lexicon badly needed. Biol Psychiatry. 2012;73:e15–24. Salamone JD, Correa M. Dopamine and food addiction: lexicon badly needed. Biol Psychiatry. 2012;73:e15–24.
31.
Zurück zum Zitat Meguid MM, Yang ZJ, Koseki M. Eating induced rise in LHA-dopamine correlates with meal size in normal and bulbectomized rats. Brain Res Bull. 1995;36:487–90.PubMedCrossRef Meguid MM, Yang ZJ, Koseki M. Eating induced rise in LHA-dopamine correlates with meal size in normal and bulbectomized rats. Brain Res Bull. 1995;36:487–90.PubMedCrossRef
32.
Zurück zum Zitat Sato T et al. Hypothalamic dopaminergic receptor expressions in anorexia of tumor-bearing rats. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1907–16.PubMed Sato T et al. Hypothalamic dopaminergic receptor expressions in anorexia of tumor-bearing rats. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1907–16.PubMed
33.
Zurück zum Zitat Lozano RH, Jofre IS. Novel use of L-dOPA in the treatment of anorexia and asthenia associated with cancer. Palliat Med. 2002;16:548.PubMedCrossRef Lozano RH, Jofre IS. Novel use of L-dOPA in the treatment of anorexia and asthenia associated with cancer. Palliat Med. 2002;16:548.PubMedCrossRef
34.
35.
Zurück zum Zitat Ratner C, et al. Cerebral markers of the serotonergic system in rat models of obesity and after roux-en-Y gastric bypass. Obesity (Silver Spring). 2012;20:2133–41. Ratner C, et al. Cerebral markers of the serotonergic system in rat models of obesity and after roux-en-Y gastric bypass. Obesity (Silver Spring). 2012;20:2133–41.
36.
Zurück zum Zitat Wurtman RJ, Wurtman JJ. Brain serotonin, carbohydrate-craving, obesity and depression. Obes Res. 1995;3:477S–80S.PubMedCrossRef Wurtman RJ, Wurtman JJ. Brain serotonin, carbohydrate-craving, obesity and depression. Obes Res. 1995;3:477S–80S.PubMedCrossRef
37.
Zurück zum Zitat Madras BK et al. Elevation of serum free tryptophan, but not brain tryptophan, by serum nonesterified fatty acids. Adv Biochem Psychopharmacol. 1974;11:143–51.PubMed Madras BK et al. Elevation of serum free tryptophan, but not brain tryptophan, by serum nonesterified fatty acids. Adv Biochem Psychopharmacol. 1974;11:143–51.PubMed
38.
Zurück zum Zitat Molfino A et al. Free tryptophan/large neutral amino acids ratios in blood plasma do not predict cerebral spinal fluid tryptophan concentrations in interleukin-1-induced anorexia. Pharmacol Biochem Behav. 2008;89:31–5.PubMedCrossRef Molfino A et al. Free tryptophan/large neutral amino acids ratios in blood plasma do not predict cerebral spinal fluid tryptophan concentrations in interleukin-1-induced anorexia. Pharmacol Biochem Behav. 2008;89:31–5.PubMedCrossRef
39.
Zurück zum Zitat Sato T et al. Involvement of plasma leptin, insulin and free tryptophan in cytokine-induced anorexia. Clin Nutr. 2003;22:139–46.PubMedCrossRef Sato T et al. Involvement of plasma leptin, insulin and free tryptophan in cytokine-induced anorexia. Clin Nutr. 2003;22:139–46.PubMedCrossRef
40.
Zurück zum Zitat Bossola M et al. Anorexia and plasma levels of free tryptophan, branched chain amino acids, and ghrelin in hemodialysis patients. J Ren Nutr. 2009;19:248–55.PubMedCrossRef Bossola M et al. Anorexia and plasma levels of free tryptophan, branched chain amino acids, and ghrelin in hemodialysis patients. J Ren Nutr. 2009;19:248–55.PubMedCrossRef
41.
Zurück zum Zitat Koren MS et al. Changes in plasma amino acid levels do not predict satiety and weight loss on diets with modified macronutrient composition. Ann Nutr Metab. 2007;51:182–7.PubMedCrossRef Koren MS et al. Changes in plasma amino acid levels do not predict satiety and weight loss on diets with modified macronutrient composition. Ann Nutr Metab. 2007;51:182–7.PubMedCrossRef
42.
Zurück zum Zitat Newgard CB et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311–26.PubMedCentralPubMedCrossRef Newgard CB et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311–26.PubMedCentralPubMedCrossRef
43.
Zurück zum Zitat Argiles JM et al. Catabolic mediators as targets for cancer cachexia. Drug Discov Today. 2003;8:838–44.PubMedCrossRef Argiles JM et al. Catabolic mediators as targets for cancer cachexia. Drug Discov Today. 2003;8:838–44.PubMedCrossRef
44.
Zurück zum Zitat Asp ML et al. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. Int J Cancer. 2010;126:756–63.PubMedCrossRef Asp ML et al. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. Int J Cancer. 2010;126:756–63.PubMedCrossRef
45.
Zurück zum Zitat Joppa MA et al. Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83–132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice. Peptides. 2007;28:636–42.PubMedCrossRef Joppa MA et al. Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83–132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice. Peptides. 2007;28:636–42.PubMedCrossRef
46.
Zurück zum Zitat Chance WT et al. Alteration of NPY and Y1 receptor in dorsomedial and ventromedial areas of hypothalamus in anorectic tumor-bearing rats. Peptides. 2007;28:295–301.PubMedCrossRef Chance WT et al. Alteration of NPY and Y1 receptor in dorsomedial and ventromedial areas of hypothalamus in anorectic tumor-bearing rats. Peptides. 2007;28:295–301.PubMedCrossRef
47.
Zurück zum Zitat Nara-ashizawa N et al. Response of hypothalamic NPY mRNAs to a negative energy balance is less sensitive in cachectic mice bearing human tumor cells. Nutr Cancer. 2001;41:111–8.PubMedCrossRef Nara-ashizawa N et al. Response of hypothalamic NPY mRNAs to a negative energy balance is less sensitive in cachectic mice bearing human tumor cells. Nutr Cancer. 2001;41:111–8.PubMedCrossRef
48.
Zurück zum Zitat Dryden S et al. Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine. Brain Res. 1996;724:232–7.PubMedCrossRef Dryden S et al. Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine. Brain Res. 1996;724:232–7.PubMedCrossRef
49.
Zurück zum Zitat Shinozaki T et al. Fluvoxamine inhibits weight gain and food intake in food restricted hyperphagic Wistar rats. Biol Pharm Bull. 2008;31:2250–4.PubMedCrossRef Shinozaki T et al. Fluvoxamine inhibits weight gain and food intake in food restricted hyperphagic Wistar rats. Biol Pharm Bull. 2008;31:2250–4.PubMedCrossRef
Metadaten
Titel
Hypothalamic food intake regulation in a cancer-cachectic mouse model
verfasst von
Jvalini T. Dwarkasing
Miriam van Dijk
Francina J. Dijk
Mark V. Boekschoten
Joyce Faber
Josep M. Argilès
Alessandro Laviano
Michael Müller
Renger F. Witkamp
Klaske van Norren
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cachexia, Sarcopenia and Muscle / Ausgabe 2/2014
Print ISSN: 2190-5991
Elektronische ISSN: 2190-6009
DOI
https://doi.org/10.1007/s13539-013-0121-y

Weitere Artikel der Ausgabe 2/2014

Journal of Cachexia, Sarcopenia and Muscle 2/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.